| 1. |
Bataller R,Brenner DA.Liver fibrosis[J].J Clini Res,2005,115:209-218.
|
| 2. |
中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].胃肠病学,2011,16(6):351-366.
|
| 3. |
蔡卫民,张彬彬,翁红雷,等.八项肝纤维化血清标志物比较研究[J].中华肝脏病杂志,2004,12(4):219-222.
|
| 4. |
Gressner OA,Weiskirchen R,Gressner AM.Biomarkers of hepatic fibrosis,fibrogenesis and genetic pre-disposition pending between fiction and reality[J].J Cell Mol Med,2007,11(5):1031-1051.
|
| 5. |
Dufour DR.Assessment of liver fibrosis:can serum become the sample of choice?[J].Clin Chem,2005,51(10):1763-1764.
|
| 6. |
胡义扬,刘平,刘成,等.基于肝组织病理动态变化情况探讨血清学指标在肝纤维化诊断中的意义[J].中华肝脏病杂志,2006,14(3):174-177.
|
| 7. |
Mummadi RR,Petersen JR,Xiao SY,et al.Role of simple biomarkers in predicting fibrosis progression in HCV infection[J].World J Gastroenterol,2010,16(45):5710-5715.
|
| 8. |
Consolo M,Amoroso A,Spandidos DA,et al.Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease (review)[J].Int J Mol Med,2009,24(2):143-152.
|
| 9. |
Badra G,Lotfy M,El-Refaie A,et al.Significance of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in chronic hepatitis C patients[J].Acta Microbiol Immunol Hung,2010,57(1):29-42.
|
| 10. |
白凯,郭存九.基质金属蛋白酶和纤溶酶原激活物及其抑制物在肝纤维化进程中的作用[J].中华肝脏病杂志,2006,14(6):459-461.
|
| 11. |
尹珊珊,李新民,王宝恩,等.血清胶原酶对判断慢性乙型肝炎肝纤维化及炎症程度的意义[J].中华肝脏病杂志,2004,12(11):666-668.
|
| 12. |
Chacko G.Matrix metalloproteinases[J].Neurol India,2011,59(2):224-225.
|
| 13. |
Zeremski M,Dimova R,Brown Q,et al.Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection[J].J Infect Dis,2009,200(11):1774-1780.
|
| 14. |
Zeremski M,Petrovic LM,Chiriboga L,et al.Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C[J].Hepatology,2008,48(5):1440-1450.
|
| 15. |
Cummings J,Ranson M,Butt F,et al.Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death:long term antigen stability in cancer patient plasma[J].Cancer Chemother Pharmacol,2007,60(6):921-924.
|
| 16. |
Yilmaz Y,Dolar E,Ulukaya E,et al.Soluble forms of extracellular cytokeratin 18 May differentiate simple steatosis from nonalcoholic steatohepatitis[J].World J Gastroenterol,2007,13(6):837-844.
|
| 17. |
Lim AK,Taylor-Robinson SD,Patel N,et al.Hepatic vein Transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C[J].Gut,2005,54(1):128-133.
|
| 18. |
Pedersen JF,Larsen VA,Bytzer P,et al.Hepatic Transit time of ultrasound contrast in biopsy characterized liver disease[J].Acta Radiol,2005,46(6):557-560.
|
| 19. |
Abbattista T,Ridolfi F,Ciabattoni E,et al.Diagnosis of liver cirrhosis by transit-time analysis at contrast-enhanced ultrasonography[J].Radiol Med,2008,113(6):860-874.
|
| 20. |
Ridolfi F,Abbattista T,Marini F,et al.Contrast-enhanced ultrasound to evaluate the severity of chronic hepatitis C[J].Dig Liver Dis,2007,39(10):929-935.
|
| 21. |
Searle J,Mendelson R,Zelesco M,et al.Non-invasive prediction of the degree of liver fibrosis in patients with hepatitis C using an ultrasound contrast agent.A pilot study[J].J Med Imaging Radiat Oncol,2008,52(2):130-133.
|
| 22. |
史丽静,李树平,田建明,等.CT灌注、MR灌注及MR扩散加权成像对肝脏疾病鉴别能力的比较[J].中国临床医学影像杂志,2007,18(12):884-888.
|
| 23. |
Nakashige A,Horiguchi J,Tamura A,et al.Quantitative measurement of hepatic portal perfusion by multidetector row CT with compensation for respiratory misregistration[J].Br J Radiol,2004,77(921):728-734.
|
| 24. |
程悦,沈文,祁吉.MR扩散加权成像和CT灌注成像对肝纤维化诊断价值的比较[J].中国医学影像技术,2010,2(26):297-300.
|
| 25. |
Aubé C,Racineux PX,Lebigot J,et al.Diagnosis and quantification of hepatic fibrosis with diffusion weighted Mr imaging:preliminary results[J].J Radiol,2004,85(3):301-306.
|
| 26. |
Taouli B,Vilgrain V,Dumont E,et al.Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences:prospective study in 66 patients[J].Radiology,2003,226(1):71-78.
|
| 27. |
Greenleaf JF,Fatemi M,Insana M.Selected methods for imaging elastic properties of biological tissues[J].Annu Rev Biomed Eng,2003(5):57-78.
|
| 28. |
Vergniol J,De Lédinghen V.Transient elastography (FibroScan):a new tool in hepatology[J].Presse Med,2009,38(10):1516-1525.
|
| 29. |
Forns X,Ampurdanès S,Llovet JM,et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J].Hepatology,2002,36(4 Pt 1):986-992.
|
| 30. |
Foucher J,Chanteloup E,Vergniol J,et al.Diagnosis of cirrhosis by transient elastography (FibroScan):a prospective study[J].Gut,2006,55(3):403-408.
|
| 31. |
Bureau C,Metivier S,Peron JM,et al.Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease[J].Aliment Pharmacol Ther,2008,27(12):1261-1268.
|
| 32. |
Ziol M,Handra-Luca A,Kettaneh A,et al.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J].Hepatology,2005,41(1):48-54.
|
| 33. |
Chan HL,Wong GL,Choi PC,et al.Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (FibroScan) for liver fibrosis in chronic hepatitis B[J].J Viral Hepat,2009,16(1):36-44.
|
| 34. |
Tsochatzis EA,Gurusamy KS,Ntaoula S,et al.Elastography for the diagnosis of severity of fibrosis in chronic liver disease:a meta-analysis of diagnostic accuracy[J].J Hepatol,2011,54(4):650-659.
|
| 35. |
De Lédinghen V,Le Bail B,Rebouissoux L,et al.Liver stiffness measurement in children using FibroScan:feasibility study and comparison with Fibrotest,aspartate transaminase to platelets ratio index,and liver biopsy[J].J Pediatr Gastroenterol Nutr,2007,45(4):443-450.
|
